This site is inspired by the work of David Servan-Schreiber and scientific literature on nutrition and cancer prevention. It does not replace medical advice and does not constitute a treatment.

Back to catalog
🟡

Turmeric

Strong evidence

Active compounds

Curcumine

Targeted cancers

colonprostatelungliverstomachbreastovaryleukemiapancreasmultiple myeloma

Anti-cancer actions

  • Powerful anti-inflammatory — inhibits NF-kB, the main inflammatory pathway
  • Inhibits the growth of many cancers: colon, prostate, lung, liver, stomach, breast, ovary, leukemia
  • Blocks angiogenesis
  • Forces cancer cells into apoptosis (cellular suicide)
  • Reduces metastases of Taxol-resistant breast cancer (Aggarwal study, MD Anderson 2005)

How to prepare it

Mix with black pepper (piperine multiplies curcumin absorption by 20) and olive oil. Use in curries, soups, and salad dressings.

Recommended dosage

1/4 to 1/2 teaspoon per day, consistently combined with black pepper.

⚗️ Food synergies

These foods potentiate the effects of Turmeric

Scientific sources

  • Aggarwal BB et al. — MD Anderson Cancer Center, Houston (2005)
  • 4 clinical trials launched by MD Anderson: multiple myeloma, pancreas, lung, colon

🔬 Studies from Dr. Béliveau's laboratory

All publications →
2010MolStrong evidence

Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts

Perry MC, Demeule M, Régina A, Moumdjian R, Béliveau R

La curcumine provoque une régression significative de xénogreffes de glioblastome chez la souris, ouvrant la voie à des essais cliniques en neuro-oncologie.

Régression tumorale par inhibition de NF-κB et induction de l'apoptose

Source: richardbeliveau.orgRead article
2006FEBS Letters  580(15):3746-3752

Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: Potential new anticancer target for curcumin

Belkaid A., Copland IB., Massillon D. & Annabi B.

La curcumine cible G6PT (glucose-6-phosphate translocase), une protéine surexprimée dans les cellules cancéreuses résistantes aux médicaments conventionnels.

Inhibition de G6PT, cible anticancer dans la résistance aux médicaments

Source: richardbeliveau.orgRead article